electroCore, Inc. (NASDAQ:ECOR – Get Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 288,100 shares, a growth of 136.9% from the February 28th total of 121,600 shares. Based on an average daily trading volume, of 155,400 shares, the short-interest ratio is presently 1.9 days. Currently, 5.0% of the shares of the company are sold short.
Wall Street Analyst Weigh In
Several brokerages have commented on ECOR. HC Wainwright restated a “buy” rating and issued a $25.00 target price on shares of electroCore in a research note on Thursday, March 13th. LADENBURG THALM/SH SH cut their price objective on shares of electroCore from $28.00 to $26.00 and set a “buy” rating for the company in a research report on Thursday, March 13th.
Get Our Latest Stock Report on ECOR
Insider Buying and Selling at electroCore
Institutional Trading of electroCore
Several institutional investors and hedge funds have recently modified their holdings of the business. Renaissance Technologies LLC raised its stake in electroCore by 80.6% in the fourth quarter. Renaissance Technologies LLC now owns 131,786 shares of the company’s stock valued at $2,136,000 after purchasing an additional 58,800 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of electroCore by 10.3% in the 3rd quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock worth $458,000 after buying an additional 5,951 shares during the last quarter. HighTower Advisors LLC bought a new position in shares of electroCore in the 3rd quarter worth $255,000. Marshall Wace LLP purchased a new stake in shares of electroCore during the 4th quarter valued at $438,000. Finally, Jane Street Group LLC bought a new stake in shares of electroCore during the 4th quarter worth $278,000. Hedge funds and other institutional investors own 26.74% of the company’s stock.
electroCore Trading Down 5.3 %
Shares of electroCore stock traded down $0.36 during trading on Friday, hitting $6.45. The stock had a trading volume of 171,686 shares, compared to its average volume of 71,753. The firm has a market cap of $46.39 million, a price-to-earnings ratio of -3.52 and a beta of 0.24. electroCore has a 12 month low of $5.32 and a 12 month high of $19.49. The business’s 50-day moving average is $14.27 and its 200 day moving average is $12.37.
About electroCore
electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
Further Reading
- Five stocks we like better than electroCore
- Where to Find Earnings Call Transcripts
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- How to Choose Top Rated Stocks
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.